Beyond Discovery: Advances and Future Directions in Drug Repurposing Strategies a Review Article

Read full text Summarise with VIRAT
Authors: Prathyusha. V, R.Prem Sai
Cited by: 0
References: 23

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

A new paradigm known as "drug repurposing" or "drug repositioning" finds new therapeutic applications for licensed or novel medications outside of their initial medical indications.Due to its lower risk, faster screening times, and cost-effectiveness as compared to traditional drug discovery, which necessitates thorough preclinical and clinical testing, it has grown in popularity.Repurposed medications enable faster clinical translation and higher success rates because they already have established pharmacokinetic, safety, and toxicity characteristics.Drug repurposing has been facilitated by a variety of tactics, such as on-target and off-target methods that make use of either well-established mechanisms or recently discovered biological interactions.Largescale data mining and drug-disease association prediction have been made possible by advances in computing technologies, particularly artificial intelligence, machine learning, network-based method, and bioinformatics, which have revolutionized repurposing.Computational simulations are validated by complementary experimental methods including genome-wide CRISPR-Cas9 research and phenotypic screening.The discovery of repurposing signals in clinical populations is further supported by realworld data sources, including electronic health records, claims databases, and multimodal datasets.Despite having benefits, there are also issues associated with drug repurposing such as restrictions on intellectual property, complicated regulations, issues with data veracity, and a dearth of common benchmarking datasets for predictive models.With an emphasis on the growing importance of AI and data-driven analytics in accelerating therapeutic innovation and solving unmet clinical needs, this study offers an overview of current approaches, techniques, applications, and constraints related to drug repurposing.

Fields of Study & Subjects

Computational Drug Discovery Methods Pharmaceutical Economics and Policy Pharmaceutical studies and practices

Publication details

Journal / source
International Journal of Pharmacy and Pharmaceutical Research
Volume
32
Issue
3
Pages
354–360
Publication date
1 January 2026
Language
EN